New Jersey A 3705: Provides parties offering public remarks before Senate committee concerning qualifications of Superior Court judge nominees, upon motion, change of venue on family actions, to vicinage other than vicinage where nominee is assigned if confirmed.

Bill Text

A3705 

ASSEMBLY, No. 3705 

STATE OF NEW JERSEY

222nd LEGISLATURE

� 

PRE-FILED FOR INTRODUCTION IN THE 2026 SESSION

Sponsored by:

Assemblywoman ALIXON COLLAZOS-GILL

District 27 (Essex and Passaic)

Assemblywoman� HEATHER SIMMONS

District 3 (Cumberland, Gloucester and Salem)

Co-Sponsored by:

Assemblywoman Brennan

SYNOPSIS

���� Waives 15 day waiting period for medical aid in dying 
under certain circumstances.

CURRENT VERSION OF TEXT 

���� Introduced Pending Technical Review by Legislative 
Counsel.

�� 

An Act concerning medical aid in dying and amending P.L.2019, 
c.59.

���� Be It 
Enacted by the Senate and General Assembly of 
the State of New Jersey:

���� 1.� Section 10 of P.L.2019, 
c.59 (C.26:16-10) is amended to read as follows:� 

���� 10. a. In order to receive a 
prescription for medication that a qualified terminally ill patient may choose 
to self-administer pursuant to P.L.2019, c.59 (C.26:16-1 et al.), the patient 
shall make two oral requests and one written request for the medication to the 
patient's attending physician, subject to the following requirements:

���� (1)�� at least 15 days shall 
elapse between the initial oral request and the second oral request unless, 
within reasonable medical certainty, the patient is not expected to survive for 
15 days, in which case the requirement for a second oral request may be waived;

���� (2)�� at the time the patient 
makes a second oral request, the attending physician shall offer the patient an 
opportunity to rescind the request;

���� (3)�� the patient may submit 
the written request to the attending physician when the patient makes the 
initial oral request or at any time thereafter;

���� (4)�� the written request 
shall meet the requirements of section 5 of P.L.2019, c.59 (C.26:16-5);

���� (5)�� at least 15 days shall 
elapse between the patient's initial oral request and the writing of a 
prescription pursuant to P.L.2019, c.59 (C.26:16-1 et al.) unless, within 
reasonable medical certainty, the patient is not expected to survive for 15 
days, in which case at least 48 hours shall elapse between the patient�s 
initial oral request and the writing of a prescription pursuant to P.L.2019, 
c.59 (C.26:6-1 et al.); and

���� (6)�� at least 48 hours shall 
elapse between the attending physician's receipt of the patient's written 
request and the writing of a prescription pursuant to P.L.2019, c.59 (C.26:16-1 
et al.).

���� b.��� A qualified terminally 
ill patient may rescind the request at any time and in any manner without 
regard to the patient's mental state.

���� c.���� At the time the patient 
makes an initial oral request for medication that the patient may choose to 
self-administer pursuant to P.L.2019, c.59 (C.26:16-1 et al.), the patient's 
attending physician shall recommend to the patient that the patient participate 
in a consultation concerning concurrent or additional treatment opportunities, 
palliative care, comfort care, hospice care, and pain control options, and 
provide the patient with a referral to a health care professional qualified to 
discuss these options with the patient.� If the patient chooses to participate 
in such consultation, the consultation shall include, to the extent the patient 
consents to share such information, consideration of: the patient's terminal 
illness; the patient's prognosis; current and past courses of treatment 
prescribed for the patient in connection with the patient's terminal illness, 
including the results of any such treatment; and any palliative care, comfort 
care, hospice care, and pain control treatment the patient is currently 
receiving or has received in the past.

���� d.��� The attending physician 
shall ensure that the following items are included in the patient's medical 
record:

���� (1)�� the determination that 
the patient is a qualified terminally ill patient and the basis for that 
determination;

���� (2)�� all oral and written 
requests by the patient to the attending physician for medication that the 
patient may choose to self-administer pursuant to P.L.2019, c.59 (C.26:16-1 et 
al.);

���� (3)�� the attending 
physician's diagnosis and prognosis, and determination that the patient is 
capable, is acting voluntarily, and has made an informed decision;

���� (4)�� the consulting 
physician's diagnosis and prognosis, and verification that the patient is 
capable, is acting voluntarily, and has made an informed decision;

���� (5)�� if applicable, a report 
of the determination made by a mental health care professional as to whether 
the patient is capable pursuant to section 8 of P.L.2019, c.59 (C.26:16-8);

���� (6)�� the attending 
physician's recommendation that the patient participate in a consultation 
concerning concurrent or additional treatment opportunities, palliative care, 
comfort care, hospice care, and pain control options; the referral provided to 
the patient with a referral to a health care professional qualified to discuss 
th